July 25, 2014
As reported by the Senate Committee on Health, Education, Labor, and Pensions on July 23, 2014
S. 315 would amend the Public Health Service Act to reauthorize surveillance, research, and education activities relating to muscular dystrophy. The bill would expand the portfolios of the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to include additional forms of muscular dystrophy. It also would direct CDC to capture more representative data regarding muscular dystrophy across populations.
CBO estimates that implementing S. 315 would cost $323 million over the 2015-2019 period, assuming appropriation of the necessary amounts. Pay-as-you-go procedures do not apply to this legislation because it would not affect direct spending or revenues.
S. 315 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act.